{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:32:25Z","timestamp":1794547945476,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62628-7","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T13:51:57Z","timestamp":1755352317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Regulatory T cell therapy promotes TGF-\u03b2 and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2"],"prefix":"10.1038","volume":"16","author":[{"given":"Hao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hantian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-9920","authenticated-orcid":false,"given":"Hiroko","family":"Nakatsukasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-2462","authenticated-orcid":false,"given":"Huiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9481-9807","authenticated-orcid":false,"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-2382","authenticated-orcid":false,"given":"Xikun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-0690","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-7641","authenticated-orcid":false,"given":"Hongbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-2114","authenticated-orcid":false,"given":"WanJun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5665-0139","authenticated-orcid":false,"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-9930","authenticated-orcid":false,"given":"Dunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"62628_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"key":"62628_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"62628_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","volume":"21","author":"S Sakaguchi","year":"2009","unstructured":"Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. & Yamaguchi, T. Regulatory T cells: how do they suppress immune responses?. Int. Immunol. 21, 1105\u20131111 (2009).","journal-title":"Int. Immunol."},{"key":"62628_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DAA Vignali","year":"2008","unstructured":"Vignali, D. A. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523\u2013532 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"62628_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","volume":"20","author":"C Raffin","year":"2020","unstructured":"Raffin, C., Vo, L. T. & Bluestone, J. A. T(reg) cell-based therapies: challenges and perspectives. Nat. Rev. Immunol. 20, 158\u2013172 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"62628_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","volume":"18","author":"LMR Ferreira","year":"2019","unstructured":"Ferreira, L. M. R., Muller, Y. D., Bluestone, J. A. & Tang, Q. Next-generation regulatory T cell therapy. Nat. Rev. Drug Discov. 18, 749\u2013769 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62628_CR7","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3389\/fimmu.2018.02359","volume":"9","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Chimeric Antigen Receptor (CAR) treg: A promising approach to inducing immunological tolerance. Front. Immunol. 9, 2359 (2018).","journal-title":"Front. Immunol."},{"key":"62628_CR8","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bbmt.2013.06.004","volume":"19","author":"CG Brunstein","year":"2013","unstructured":"Brunstein, C. G. et al. Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation. Biol. Blood Marrow Transpl. 19, 1271\u20131273 (2013).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"62628_CR9","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20040180","volume":"199","author":"KV Tarbell","year":"2004","unstructured":"Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P. & Steinman, R. M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467\u20131477 (2004).","journal-title":"J. Exp. Med."},{"key":"62628_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/eji.200839073","volume":"39","author":"LA Stephens","year":"2009","unstructured":"Stephens, L. A., Malpass, K. H. & Anderton, S. M. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur. J. Immunol. 39, 1108\u20131117 (2009).","journal-title":"Eur. J. Immunol."},{"key":"62628_CR11","doi-asserted-by":"publisher","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","volume":"3","author":"P Sagoo","year":"2011","unstructured":"Sagoo, P. et al. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci. Transl. Med. 3, 83ra42 (2011).","journal-title":"Sci. Transl. Med."},{"key":"62628_CR12","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.transproceed.2013.01.073","volume":"45","author":"F Noyan","year":"2013","unstructured":"Noyan, F. et al. Donor-specific regulatory T cells generated on donor B cells are superior to CD4+CD25high cells in controlling alloimmune responses in humanized mice. Transpl. Proc. 45, 1832\u20131837 (2013).","journal-title":"Transpl. Proc."},{"key":"62628_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1073\/pnas.0903158107","volume":"107","author":"JY Humrich","year":"2010","unstructured":"Humrich, J. Y. et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc. Natl. Acad. Sci. USA 107, 204\u2013209 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62628_CR14","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","volume":"365","author":"J Koreth","year":"2011","unstructured":"Koreth, J. et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365, 2055\u20132066 (2011).","journal-title":"N. Engl. J. Med."},{"key":"62628_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","volume":"15","author":"D Klatzmann","year":"2015","unstructured":"Klatzmann, D. & Abbas, A. K. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283\u2013294 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"62628_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.it.2012.07.007","volume":"33","author":"EM Shevach","year":"2012","unstructured":"Shevach, E. M. Application of IL-2 therapy to target T regulatory cell function. Trends Immunol. 33, 626\u2013632 (2012).","journal-title":"Trends Immunol."},{"key":"62628_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","volume":"36","author":"A Ballesteros-Tato","year":"2012","unstructured":"Ballesteros-Tato, A. et al. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 36, 847\u2013856 (2012).","journal-title":"Immunity"},{"key":"62628_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni.1995","volume":"12","author":"XP Yang","year":"2011","unstructured":"Yang, X. P. et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247\u2013254 (2011).","journal-title":"Nat. Immunol."},{"key":"62628_CR19","doi-asserted-by":"publisher","first-page":"eabn7774","DOI":"10.1126\/sciadv.abn7774","volume":"8","author":"X Chi","year":"2022","unstructured":"Chi, X. et al. RORgammat expression in mature T(H)17 cells safeguards their lineage specification by inhibiting conversion to T(H)2 cells. Sci. Adv. 8, eabn7774 (2022).","journal-title":"Sci. Adv."},{"key":"62628_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-pathol-011110-130318","volume":"8","author":"CT Weaver","year":"2013","unstructured":"Weaver, C. T., Elson, C. O., Fouser, L. A. & Kolls, J. K. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8, 477\u2013512 (2013).","journal-title":"Annu. Rev. Pathol."},{"key":"62628_CR21","doi-asserted-by":"publisher","unstructured":"Bender, C. et al. A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Sci. Transl. Med. 16, https:\/\/doi.org\/10.1126\/scitranslmed.adn2404 (2024).","DOI":"10.1126\/scitranslmed.adn2404"},{"key":"62628_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","volume":"133","author":"P Trzonkowski","year":"2009","unstructured":"Trzonkowski, P. et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin. Immunol. 133, 22\u201326 (2009).","journal-title":"Clin. Immunol."},{"key":"62628_CR23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/eji.201242771","volume":"43","author":"E Tu","year":"2013","unstructured":"Tu, E., Bourges, D., Gleeson, P. A., Ang, D. K. & van Driel, I. R. Pathogenic T cells persist after reversal of autoimmune disease by immunosuppression with regulatory T cells. Eur. J. Immunol. 43, 1286\u20131296 (2013).","journal-title":"Eur. J. Immunol."},{"key":"62628_CR24","doi-asserted-by":"publisher","first-page":"241ra278","DOI":"10.1126\/scitranslmed.3008895","volume":"6","author":"S Kasagi","year":"2014","unstructured":"Kasagi, S. et al. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response. Sci. Transl. Med. 6, 241ra278 (2014).","journal-title":"Sci. Transl. Med."},{"key":"62628_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1600-6143.2007.02088.x","volume":"8","author":"G Xia","year":"2008","unstructured":"Xia, G., He, J. & Leventhal, J. R. Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am. J. Transpl. 8, 298\u2013306 (2008).","journal-title":"Am. J. Transpl."},{"key":"62628_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ajt.12509","volume":"14","author":"K Lee","year":"2014","unstructured":"Lee, K., Nguyen, V., Lee, K. M., Kang, S. M. & Tang, Q. Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy. Am. J. Transpl. 14, 27\u201338 (2014).","journal-title":"Am. J. Transpl."},{"key":"62628_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.immuni.2011.08.012","volume":"35","author":"Y Wang","year":"2011","unstructured":"Wang, Y., Su, M. A. & Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337\u2013348 (2011).","journal-title":"Immunity"},{"key":"62628_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1034\/j.1600-065X.2001.1820115.x","volume":"182","author":"B Singh","year":"2001","unstructured":"Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190\u2013200 (2001).","journal-title":"Immunol. Rev."},{"key":"62628_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057\u20131061 (2003).","journal-title":"Science"},{"key":"62628_CR30","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","volume":"112","author":"LA Monticelli","year":"2015","unstructured":"Monticelli, L. A. et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc. Natl. Acad. Sci. USA 112, 10762\u201310767 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62628_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-022-05297-6","volume":"611","author":"AM Tsou","year":"2022","unstructured":"Tsou, A. M. et al. Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces. Nature 611, 787\u2013793 (2022).","journal-title":"Nature"},{"key":"62628_CR32","doi-asserted-by":"publisher","unstructured":"Cui, W. et al. Diet-mediated constitutive induction of novel IL-4+ ILC2 cells maintains intestinal homeostasis in mice. J. Exp. Med. 220, https:\/\/doi.org\/10.1084\/jem.20221773 (2023).","DOI":"10.1084\/jem.20221773"},{"key":"62628_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.immuni.2019.08.001","volume":"51","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. High glucose intake exacerbates autoimmunity through reactive-oxygen-species-mediated TGF-beta cytokine activation. Immunity 51, 671\u2013681 (2019).","journal-title":"Immunity"},{"key":"62628_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ni.1774","volume":"10","author":"X Zhou","year":"2009","unstructured":"Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000\u20131007 (2009).","journal-title":"Nat. Immunol."},{"key":"62628_CR35","doi-asserted-by":"crossref","unstructured":"Ma, S. Y. et al. ROR\u03b3t phosphorylation protects against T cell-mediated inflammation. Cell Rep. 38, 110520 (2022).","DOI":"10.1016\/j.celrep.2022.110520"},{"key":"62628_CR36","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","volume":"163","author":"C Wang","year":"2015","unstructured":"Wang, C. et al. CD5L\/AIM Regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell 163, 1413\u20131427 (2015).","journal-title":"Cell"},{"key":"62628_CR37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967\u2013971 (2010).","journal-title":"Nature"},{"key":"62628_CR38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991\u2013999 (2012).","journal-title":"Nat. Immunol."},{"key":"62628_CR39","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","volume":"184","author":"A Schnell","year":"2021","unstructured":"Schnell, A. et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell 184, 6281\u20136298 (2021).","journal-title":"Cell"},{"key":"62628_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08404-w","volume":"10","author":"K Yasuda","year":"2019","unstructured":"Yasuda, K. et al. Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation. Nat. Commun. 10, 549 (2019).","journal-title":"Nat. Commun."},{"key":"62628_CR41","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.celrep.2016.05.088","volume":"16","author":"G Meyer Zu Horste","year":"2016","unstructured":"Meyer Zu Horste, G. et al. RBPJ Controls development of pathogenic Th17 cells by regulating IL-23 receptor expression. Cell Rep. 16, 392\u2013404 (2016).","journal-title":"Cell Rep."},{"key":"62628_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/75068","volume":"6","author":"R Atreya","year":"2000","unstructured":"Atreya, R. et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat. Med. 6, 583\u2013588 (2000).","journal-title":"Nat. Med."},{"key":"62628_CR43","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1053\/j.gastro.2005.01.013","volume":"128","author":"Y Kai","year":"2005","unstructured":"Kai, Y. et al. Colitis in mice lacking the common cytokine receptor gamma chain is mediated by IL-6-producing CD4+ T cells. Gastroenterology 128, 922\u2013934 (2005).","journal-title":"Gastroenterology"},{"key":"62628_CR44","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1111\/ajt.16459","volume":"21","author":"S Chandran","year":"2021","unstructured":"Chandran, S. et al. Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial. Am. J. Transpl. 21, 2543\u20132554 (2021).","journal-title":"Am. J. Transpl."},{"key":"62628_CR45","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ni1391","volume":"7","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen, M., Hocking, R. J., Flavell, R. A. & Stockinger, B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7, 1151\u20131156 (2006).","journal-title":"Nat. Immunol."},{"key":"62628_CR46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2017.03.015","volume":"46","author":"JE Konkel","year":"2017","unstructured":"Konkel, J. E. et al. Transforming growth factor-\u03b2 signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses. Immunity 46, 660\u2013674 (2017).","journal-title":"Immunity"},{"key":"62628_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","volume":"26","author":"A Laurence","year":"2007","unstructured":"Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371\u2013381 (2007).","journal-title":"Immunity"},{"key":"62628_CR48","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461\u20131463 (2006).","journal-title":"Science"},{"key":"62628_CR49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"62628_CR50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1084\/jem.20150568","volume":"213","author":"CC Lin","year":"2016","unstructured":"Lin, C. C. et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J. Exp. Med. 213, 251\u2013271 (2016).","journal-title":"J. Exp. Med."},{"key":"62628_CR51","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/rheumatology\/kep316","volume":"48","author":"L Oslejskova","year":"2009","unstructured":"Oslejskova, L. et al. Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis. Rheumatology48, 1590\u20131594 (2009).","journal-title":"Rheumatology"},{"key":"62628_CR52","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1172\/JCI9012","volume":"105","author":"XF Bai","year":"2000","unstructured":"Bai, X. F. et al. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J. Clin. Invest. 105, 1227\u20131232 (2000).","journal-title":"J. Clin. Invest."},{"key":"62628_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.immuni.2020.01.006","volume":"52","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Febrile temperature critically controls the differentiation and pathogenicity of T helper 17 cells. Immunity 52, 328\u2013341 (2020).","journal-title":"Immunity"},{"key":"62628_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4049\/jimmunol.177.1.209","volume":"177","author":"W Hansen","year":"2006","unstructured":"Hansen, W. et al. G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J. Immunol. 177, 209\u2013215 (2006).","journal-title":"J. Immunol."},{"key":"62628_CR55","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.7150\/ijbs.80256","volume":"19","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Sphingosine-1-phosphate receptor 4 attenuates neutrophilic airway inflammation in experimental asthma via repressing proinflammatory macrophage activation. Int. J. Biol. Sci. 19, 1597\u20131615 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"62628_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","volume":"41","author":"WJ Chen","year":"2023","unstructured":"Chen, W. J. TGF-\u03b2 Regulation of T cells. Annu. Rev. Immunol. 41, 483\u2013512 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"62628_CR57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri.2016.112","volume":"16","author":"WJ Chen","year":"2016","unstructured":"Chen, W. J. & ten Dijke, P. Immunoregulation by members of the TGF\u03b2 superfamily. Nat. Rev. Immunol. 16, 723\u2013740 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"62628_CR58","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448\u2013457 (2015).","journal-title":"Nat. Immunol."},{"key":"62628_CR59","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13, 1235\u20131242 (2006).","journal-title":"Chem. Biol."},{"key":"62628_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","volume":"41","author":"L Goschl","year":"2019","unstructured":"Goschl, L., Scheinecker, C. & Bonelli, M. Treg cells in autoimmunity: from identification to Treg-based therapies. Semin. Immunopathol. 41, 301\u2013314 (2019).","journal-title":"Semin. Immunopathol."},{"key":"62628_CR61","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.1191996","volume":"329","author":"YP Rubtsov","year":"2010","unstructured":"Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667\u20131671 (2010).","journal-title":"Science"},{"key":"62628_CR62","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature22360","volume":"546","author":"AG Levine","year":"2017","unstructured":"Levine, A. G. et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546, 421\u2013425 (2017).","journal-title":"Nature"},{"key":"62628_CR63","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1182\/blood-2008-10-183251","volume":"113","author":"G Beriou","year":"2009","unstructured":"Beriou, G. et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113, 4240\u20134249 (2009).","journal-title":"Blood"},{"key":"62628_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.immuni.2011.02.011","volume":"34","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34, 409\u2013421 (2011).","journal-title":"Immunity"},{"key":"62628_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179\u2013189 (2006).","journal-title":"Immunity"},{"key":"62628_CR66","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.immuni.2011.03.002","volume":"34","author":"P Pandiyan","year":"2011","unstructured":"Pandiyan, P. et al. CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34, 422\u2013434 (2011).","journal-title":"Immunity"},{"key":"62628_CR67","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","volume":"4","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics. Nat. Metab. 4, 559\u2013574 (2022).","journal-title":"Nat. Metab."},{"key":"62628_CR68","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.immuni.2015.05.016","volume":"42","author":"JeeH Lee","year":"2015","unstructured":"Lee, J. eeH., Elly, C., Park, Y. & Liu, Y.-C. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1\u03b1 to Maintain Regulatory T Cell Stability and Suppressive Capacity. Immunity 42, 1062\u20131074 (2015).","journal-title":"Immunity"},{"key":"62628_CR69","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.immuni.2017.11.008","volume":"47","author":"K Essig","year":"2017","unstructured":"Essig, K. et al. Roquin suppresses the PI3K-mTOR signaling pathway to inhibit T helper cell differentiation and conversion of treg to Tfr cells. Immunity 47, 1067\u20131082.e1012 (2017).","journal-title":"Immunity"},{"key":"62628_CR70","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/art.40737","volume":"71","author":"M Dall\u2019Era","year":"2019","unstructured":"Dall\u2019Era, M. et al. Adoptive treg cell therapy in a patient with systemic Lupus erythematosus. Arthritis Rheumatol. 71, 431\u2013440 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"62628_CR71","doi-asserted-by":"publisher","unstructured":"Thonhoff, J. R. et al. Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 9, https:\/\/doi.org\/10.1212\/nxi.0000000000200019 (2022).","DOI":"10.1212\/nxi.0000000000200019"},{"key":"62628_CR72","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature05970","volume":"448","author":"T Korn","year":"2007","unstructured":"Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448, 484\u2013487 (2007).","journal-title":"Nature"},{"key":"62628_CR73","doi-asserted-by":"publisher","unstructured":"Harbour, S. N. et al. T(H)17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci. Immunol. 5, https:\/\/doi.org\/10.1126\/sciimmunol.aaw2262 (2020).","DOI":"10.1126\/sciimmunol.aaw2262"},{"key":"62628_CR74","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1146\/annurev.bi.58.070189.004303","volume":"58","author":"TA Waldmann","year":"1989","unstructured":"Waldmann, T. A. The multi-subunit interleukin-2 receptor. Annu. Rev. Biochem. 58, 875\u2013911 (1989).","journal-title":"Annu. Rev. Biochem."},{"key":"62628_CR75","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ni1536","volume":"8","author":"P Pandiyan","year":"2007","unstructured":"Pandiyan, P., Zheng, L., Ishihara, S., Reed, J. & Lenardo, M. J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8, 1353\u20131362 (2007).","journal-title":"Nat. Immunol."},{"key":"62628_CR76","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1172\/JCI90598","volume":"127","author":"Q Tang","year":"2017","unstructured":"Tang, Q. & Vincenti, F. Transplant trials with Tregs: perils and promises. J. Clin. Invest. 127, 2505\u20132512 (2017).","journal-title":"J. Clin. Invest."},{"key":"62628_CR77","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2014.07.031","volume":"158","author":"Y Feng","year":"2014","unstructured":"Feng, Y. et al. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell 158, 749\u2013763 (2014).","journal-title":"Cell"},{"key":"62628_CR78","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massague, J. Transforming growth factor-beta signaling in immunity and cancer. Immunity 50, 924\u2013940 (2019).","journal-title":"Immunity"},{"key":"62628_CR79","doi-asserted-by":"publisher","unstructured":"Dong, S.,et al. The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. JCI Insight 6, https:\/\/doi.org\/10.1172\/jci.insight.147474 (2021).","DOI":"10.1172\/jci.insight.147474"},{"key":"62628_CR80","doi-asserted-by":"publisher","first-page":"e89278","DOI":"10.1172\/jci.insight.89278","volume":"1","author":"M Hirakawa","year":"2016","unstructured":"Hirakawa, M. et al. Low-dose IL-2 selectively activates subsets of CD4(+) Tregs and NK cells. JCI Insight 1, e89278 (2016).","journal-title":"JCI Insight"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62628-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:39:28Z","timestamp":1757392768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62628"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62628-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7644"}}